Clinical Trials Directory

Trials / Completed

CompletedNCT03788031

Perceptual Learning Treatment for Amblyopia

Towards Developing a Perceptual Learning Treatment for Amblyopia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
The Hong Kong Polytechnic University · Academic / Other
Sex
All
Age
7 Years
Healthy volunteers
Accepted

Summary

Objectives. To develop a new treatment for amblyopia using a perceptual learning approach. Hypothesis to be tested. Our proposed experiments are designed to investigate whether practicing a grating detection task can improve vision in patients with amblyopia. Design and subjects. A total of 36 patients with amblyopia will be randomized allocated into two intervention groups: Group 1, perceptual learning therapy. Group 2, occlusion therapy. A control group comprising of 18 subjects with normal vision will be recruited for comparison. A battery of tests will be used to assess a range of visual functions before and after the treatment intervention. Study instruments. Grating acuity testing system Interventions. We have established a clinical protocol for acuity training. On each trial, a properly oriented stimulus will be presented randomly at one of the four locations on a flat monitor screen. The visual task is to indicate the location of the stimulus. Participants will be required to undertake 20 one-hour sessions of training. Main outcome measures. Resolution acuity, visual acuity, contrast sensitivity function

Conditions

Interventions

TypeNameDescription
OTHERAcuity trainingThe intervention will be a vision therapy. On each trial, a properly oriented stimulus will be presented randomly at one of the four locations on a flat monitor screen. The visual task is to identify the location of the stimulus.
OTHEROcclusion therapyParticipants will be required to patch the good eye for 20 days, 1 hour per day.

Timeline

Start date
2019-03-01
Primary completion
2022-12-31
Completion
2023-02-28
First posted
2018-12-27
Last updated
2024-08-29

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT03788031. Inclusion in this directory is not an endorsement.